Archives
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
Quercetin Modulates Hippo Signaling to Protect Against Catar
2026-06-03
This study demonstrates that quercetin protects against cataract development by inhibiting the Hippo signaling pathway, leading to reduced lens opacity and improved epithelial cell survival. These findings provide mechanistic insight into quercetin's therapeutic potential and highlight new avenues for pharmacological intervention in cataract prevention.
-
3D Organoid-CAF Co-cultures Reveal Stroma-Driven Chemoresist
2026-06-03
Schuth et al. advance the study of pancreatic ductal adenocarcinoma (PDAC) chemoresistance by developing a 3D co-culture system of patient-derived organoids and matched cancer-associated fibroblasts (CAFs). Their model demonstrates how stromal interactions, particularly induction of EMT and pro-inflammatory signaling, directly mediate chemoresistance, providing a robust platform for evaluating therapeutic responses in a physiologically relevant context.
-
Patient-Derived Organoids from Breast Adenomyoepithelioma: F
2026-06-02
This study presents the first successful establishment of organoids derived from a patient's adenomyoepithelioma (AME) of the breast. The resulting 3D model enables detailed exploration of AME biology, drug sensitivity, and paves the way for more tailored research on this rare tumor type.
-
DAPI (hydrochloride): Advanced DNA Imaging & Cell Analysis G
2026-06-02
DAPI (hydrochloride) is a cornerstone for DNA visualization in fixed and live cells, enabling robust cell cycle and chromosome analysis. This guide unpacks advanced protocols, experimental nuances, and troubleshooting strategies—bridging foundational workflows with next-gen multiplexed and metabolic research.
-
ML216 BLM Helicase Inhibitor: Translational Leverage in DNA
2026-06-01
Explore how ML216, a potent and selective BLM helicase inhibitor, redefines DNA repair research and synthetic lethality strategies. This thought-leadership article integrates mechanistic insights, strategic assay guidance, and translational implications for oncology, informed by recent advances in p53/PUMA-mediated apoptosis and the evolving competitive landscape.
-
Innovative CEC Method for Drug–α2-Adrenergic Receptor Bindin
2026-06-01
This study introduces a novel open-tubular capillary electrochromatography (CEC) approach for precise determination of binding constants between α2-adrenergic receptors and diverse drug molecules. The method offers reduced protein consumption and high-throughput potential, supporting advanced pharmacological research on receptor-ligand interactions.
-
PPP1R3G/PP1γ Dephosphorylation of RIPK1 Drives Cell Death Pa
2026-05-31
This study uncovers how PPP1R3G, by recruiting PP1γ, mediates the dephosphorylation and activation of RIPK1, thus promoting apoptosis and necroptosis. These insights illuminate a key regulatory axis linking inflammation, cell death, and disease, with broad implications for inflammation research and cancer biology.
-
S-Adenosylhomocysteine in Methylation Cycle Research: Applie
2026-05-30
S-Adenosylhomocysteine (SAH) empowers researchers to dissect methylation dynamics, precisely modulate the SAM/SAH ratio, and probe feedback-regulated methylation in metabolic and neurobiological assays. This guide details actionable workflows, advanced troubleshooting, and strategic protocol enhancements for deploying APExBIO’s SAH in cutting-edge experimental pipelines.
-
Fasudil (HA-1077) HCl: Selective ROCK Inhibition for Pathway
2026-05-29
Fasudil (HA-1077) HCl is a potent ROCK inhibitor used to modulate cell proliferation, migration, and apoptosis in cancer and hematological models. Its selectivity and reproducibility have made it a benchmark tool for Rho/ROCK pathway inhibition, with documented effectiveness in vitro and in vivo according to APExBIO and peer-reviewed studies. This article synthesizes mechanistic clarity, protocol parameters, and application limits for translational research.
-
DAPI (hydrochloride): Advancing DNA Visualization in Organoi
2026-05-29
DAPI (hydrochloride) empowers next-generation organoid research with robust DNA visualization and precise cell cycle analysis. This guide details evidence-based workflows, troubleshooting insights, and the latest innovations leveraging this essential chromosome staining reagent.
-
Influenza Hemagglutinin (HA) Peptide: Mechanism and Benchmar
2026-05-28
The Influenza Hemagglutinin (HA) Peptide is a high-purity, synthetic epitope tag facilitating specific protein detection and purification. This dossier details its mechanism of competitive antibody binding, solubility benchmarks, and workflow parameters for immunoprecipitation. Supported by peer-reviewed and product data, it clarifies use cases and experimental boundaries for the HA tag peptide.
-
DAPI (hydrochloride): Applied Workflows for DNA Visualizatio
2026-05-28
DAPI (hydrochloride) is a gold-standard DNA-specific fluorescent probe, optimizing chromosome staining, cell cycle analysis, and multiparameter cell assays. This article delivers actionable protocols and troubleshooting tips to empower researchers working in advanced immuno-oncology, organoid systems, and beyond.
-
Fasudil (HA-1077) HCl: Precision ROCK Inhibition in Cancer A
2026-05-27
Explore how Fasudil (HA-1077) HCl, a potent ROCK inhibitor, enables mechanistic dissection of cell proliferation and migration in advanced cancer models. This article uniquely bridges molecular selectivity, protocol parameters, and cross-pathway considerations for rigorous experimental design.
-
Quercetin Suppresses NLRP3 Inflammasome in LPS-Induced Depre
2026-05-27
This study demonstrates that quercetin attenuates depressive-like behaviors and cognitive deficits in an LPS-induced mouse model by inhibiting the hippocampal NLRP3 inflammasome pathway. The findings advance mechanistic understanding of quercetin's neuroprotective and anti-inflammatory actions, suggesting therapeutic potential for mood and cognitive symptoms in depression.
-
DAPI (hydrochloride): Technical Use and Protocol Parameters
2026-05-26
DAPI (hydrochloride) enables precise DNA visualization in histochemistry, flow cytometry, and chromosome staining workflows by binding A-T rich regions in double-stranded DNA. It is ideal for fixed cell analysis and multiparametric cell cycle studies, but requires specific handling and concentrations for live cell applications. Use is not recommended in ethanol-based protocols due to solubility constraints.